Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Finance and insurance

Department of Health and Social Care funds were allocated to Public Health England for the additional screening for AgeX. The trial analyst and trial co-ordinator are currently funded by Cancer Research UK. The University has a specialist insurance policy in place which would operate in the event of any participant suffering harm as a result of their involvement in the research (Newline Underwriting Management Ltd, at Lloyd’s of London). Appropriate contractual arrangements will be put in place with all third parties.